Bionano Genomics Stock Forecast - Naive Prediction
| BNGO Stock | USD 1.54 0.01 0.65% |
Bionano Stock outlook is based on your current time horizon. Although Bionano Genomics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Bionano Genomics' systematic risk associated with finding meaningful patterns of Bionano Genomics fundamentals over time.
As of today, the relative strength index (RSI) of Bionano Genomics' share price is approaching 45 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Bionano Genomics, making its price go up or down. Momentum 45
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (2.14) | EPS Estimate Current Year (7.72) | EPS Estimate Next Year (2.49) | Wall Street Target Price 7.5 | EPS Estimate Current Quarter (2.34) |
Using Bionano Genomics hype-based prediction, you can estimate the value of Bionano Genomics from the perspective of Bionano Genomics response to recently generated media hype and the effects of current headlines on its competitors.
Bionano Relative Strength Index
The Naive Prediction forecasted value of Bionano Genomics on the next trading day is expected to be 1.48 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 3.00.Bionano Genomics Hype to Price Pattern
Investor biases related to Bionano Genomics' public news can be used to forecast risks associated with an investment in Bionano. The trend in average sentiment can be used to explain how an investor holding Bionano can time the market purely based on public headlines and social activities around Bionano Genomics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Bionano Genomics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Bionano Genomics.
The Naive Prediction forecasted value of Bionano Genomics on the next trading day is expected to be 1.48 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 3.00. Bionano Genomics after-hype prediction price | USD 1.54 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Bionano Genomics to cross-verify your projections. Bionano Genomics Additional Predictive Modules
Most predictive techniques to examine Bionano price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bionano using various technical indicators. When you analyze Bionano charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Bionano Genomics Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Bionano Genomics' financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2016-12-31 | Previous Quarter 3.6 M | Current Value 3.1 M | Quarterly Volatility 82.3 M |
Bionano Genomics Naive Prediction Price Forecast For the 29th of January
Given 90 days horizon, the Naive Prediction forecasted value of Bionano Genomics on the next trading day is expected to be 1.48 with a mean absolute deviation of 0.05, mean absolute percentage error of 0, and the sum of the absolute errors of 3.00.Please note that although there have been many attempts to predict Bionano Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Bionano Genomics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Bionano Genomics Stock Forecast Pattern
| Backtest Bionano Genomics | Bionano Genomics Price Prediction | Buy or Sell Advice |
Bionano Genomics Forecasted Value
In the context of forecasting Bionano Genomics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Bionano Genomics' downside and upside margins for the forecasting period are 0.02 and 4.79, respectively. We have considered Bionano Genomics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Bionano Genomics stock data series using in forecasting. Note that when a statistical model is used to represent Bionano Genomics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.3768 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0483 |
| MAPE | Mean absolute percentage error | 0.0301 |
| SAE | Sum of the absolute errors | 2.9969 |
Predictive Modules for Bionano Genomics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bionano Genomics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Bionano Genomics After-Hype Price Density Analysis
As far as predicting the price of Bionano Genomics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bionano Genomics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bionano Genomics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bionano Genomics Estimiated After-Hype Price Volatility
In the context of predicting Bionano Genomics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bionano Genomics' historical news coverage. Bionano Genomics' after-hype downside and upside margins for the prediction period are 0.08 and 4.81, respectively. We have considered Bionano Genomics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bionano Genomics is very risky at this time. Analysis and calculation of next after-hype price of Bionano Genomics is based on 3 months time horizon.
Bionano Genomics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Bionano Genomics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bionano Genomics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bionano Genomics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.20 | 3.31 | 0.00 | 0.01 | 10 Events / Month | 7 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.54 | 1.54 | 0.00 |
|
Bionano Genomics Hype Timeline
Bionano Genomics is currently traded for 1.54. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Bionano is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.2%. %. The volatility of related hype on Bionano Genomics is about 4472.97%, with the expected price after the next announcement by competition of 1.53. The company has price-to-book (P/B) ratio of 0.31. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bionano Genomics recorded a loss per share of 12.77. The entity had not issued any dividends in recent years. The firm had 1:60 split on the 27th of January 2025. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Historical Fundamental Analysis of Bionano Genomics to cross-verify your projections.Bionano Genomics Related Hype Analysis
Having access to credible news sources related to Bionano Genomics' direct competition is more important than ever and may enhance your ability to predict Bionano Genomics' future price movements. Getting to know how Bionano Genomics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bionano Genomics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MYNZ | Mainz Biomed BV | 0.04 | 7 per month | 0.00 | (0.05) | 9.48 | (6.67) | 21.62 | |
| BNBX | Applied DNA Sciences | (0.18) | 9 per month | 0.00 | (0.1) | 11.56 | (13.40) | 70.35 | |
| POAI | POAI Old | 0.04 | 7 per month | 0.00 | (0.08) | 15.02 | (19.12) | 77.03 | |
| GBS | GBS Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| QNRX | Quoin Pharmaceuticals Ltd | 0.01 | 8 per month | 0.00 | (0.03) | 18.69 | (11.19) | 77.47 | |
| AIM | AIM ImmunoTech | 0.01 | 12 per month | 0.00 | (0.18) | 8.24 | (10.32) | 29.72 | |
| KTTA | Pasithea Therapeutics Corp | 0.01 | 11 per month | 7.70 | 0.07 | 16.67 | (12.50) | 137.41 | |
| VYNE | Vyne Therapeutics | 0.01 | 8 per month | 2.41 | 0.12 | 5.71 | (5.26) | 55.08 | |
| NDRA | ENDRA Life Sciences | (0.69) | 6 per month | 0.00 | (0.05) | 12.24 | (11.36) | 38.62 | |
| XTLB | XTL Biopharmaceuticals Ltd | 0.01 | 4 per month | 0.00 | (0.04) | 7.79 | (10.38) | 69.50 |
Other Forecasting Options for Bionano Genomics
For every potential investor in Bionano, whether a beginner or expert, Bionano Genomics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bionano Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bionano. Basic forecasting techniques help filter out the noise by identifying Bionano Genomics' price trends.Bionano Genomics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bionano Genomics stock to make a market-neutral strategy. Peer analysis of Bionano Genomics could also be used in its relative valuation, which is a method of valuing Bionano Genomics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bionano Genomics Market Strength Events
Market strength indicators help investors to evaluate how Bionano Genomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bionano Genomics shares will generate the highest return on investment. By undertsting and applying Bionano Genomics stock market strength indicators, traders can identify Bionano Genomics entry and exit signals to maximize returns.
Bionano Genomics Risk Indicators
The analysis of Bionano Genomics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bionano Genomics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bionano stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.34 | |||
| Standard Deviation | 3.18 | |||
| Variance | 10.13 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Bionano Genomics
The number of cover stories for Bionano Genomics depends on current market conditions and Bionano Genomics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bionano Genomics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bionano Genomics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Bionano Genomics Short Properties
Bionano Genomics' future price predictability will typically decrease when Bionano Genomics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bionano Genomics often depends not only on the future outlook of the potential Bionano Genomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bionano Genomics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.9 M | |
| Cash And Short Term Investments | 9.5 M |
Check out Historical Fundamental Analysis of Bionano Genomics to cross-verify your projections. To learn how to invest in Bionano Stock, please use our How to Invest in Bionano Genomics guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bionano Genomics. If investors know Bionano will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bionano Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (12.77) | Revenue Per Share | Quarterly Revenue Growth 0.213 | Return On Assets | Return On Equity |
The market value of Bionano Genomics is measured differently than its book value, which is the value of Bionano that is recorded on the company's balance sheet. Investors also form their own opinion of Bionano Genomics' value that differs from its market value or its book value, called intrinsic value, which is Bionano Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bionano Genomics' market value can be influenced by many factors that don't directly affect Bionano Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bionano Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bionano Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bionano Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.